Ophthalmology Therapeutics Market By Indication and Diabetic Retinopathy
Glaucoma is the largest indication segment accounting for a share of approximately 31% followed by AMD with a share of 27%. Based on end User the market is segmented into Hospitals, Eye Clinics, Diagnostic Centres and Patients.
(EMAILWIRE.COM, August 07, 2018 ) The market is showcasing evident potential in the mentioned forecasting period. Ophthalmology is the branch of medicine associated with the treatment of eye defects and diseases. With the recent advancements in genetics and stem cell biology, the mechanisms of many ophthalmic diseases are being revealed progressively.
Ophthalmology Therapeutics Market was worth $25.72 billion in 2018 and estimated to be growing at a CAGR of 7.4%, to reach $36.75 billion by 2023.
KEY POINTS OF TOC:
Market Segmentation
5.1 By Indication
5.1.1 Glaucoma
5.1.2 Dry Eye Syndrome
5.1.3 Diabetic Retinopathy
5.1.4 Retinal Vein Occlusion
5.1.5 Age-Related Macular Degeneration (AMD)
5.1.6 Macular Edema
5.1.7 Allergic Conjunctivitis
Request sample report at https://www.marketdataforecast.com/market-reports/global-ophthalmology-therapeutics-market-1106/request-sample
5.2 By End User
5.2.1 Hospitals
5.2.2 Eye Clinics
5.2.3 Diagnostic Centers
5.2.4 Patients
Browse full report at https://www.marketdataforecast.com/market-reports/global-ophthalmology-therapeutics-market-1106/
On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East.
Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc. and Roche are the major companies in the market accounting for a share of approximately 70%. Other major companies covered in the report are Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals.
Ophthalmology Therapeutics Market was worth $25.72 billion in 2018 and estimated to be growing at a CAGR of 7.4%, to reach $36.75 billion by 2023.
KEY POINTS OF TOC:
Market Segmentation
5.1 By Indication
5.1.1 Glaucoma
5.1.2 Dry Eye Syndrome
5.1.3 Diabetic Retinopathy
5.1.4 Retinal Vein Occlusion
5.1.5 Age-Related Macular Degeneration (AMD)
5.1.6 Macular Edema
5.1.7 Allergic Conjunctivitis
Request sample report at https://www.marketdataforecast.com/market-reports/global-ophthalmology-therapeutics-market-1106/request-sample
5.2 By End User
5.2.1 Hospitals
5.2.2 Eye Clinics
5.2.3 Diagnostic Centers
5.2.4 Patients
Browse full report at https://www.marketdataforecast.com/market-reports/global-ophthalmology-therapeutics-market-1106/
On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East.
Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc. and Roche are the major companies in the market accounting for a share of approximately 70%. Other major companies covered in the report are Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results